BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23510454)

  • 1. Influence of the blood-CSF-barrier function on S100B in neurodegenerative diseases.
    Steinacker P; Weidehaas K; Cepek L; Feneberg E; Kretzschmar HA; Otto M
    Acta Neurol Scand; 2013 Oct; 128(4):249-56. PubMed ID: 23510454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient.
    Castellazzi M; Morotti A; Tamborino C; Alessi F; Pilotto S; Baldi E; Caniatti LM; Trentini A; Casetta I; Granieri E; Pugliatti M; Fainardi E; Bellini T
    Fluids Barriers CNS; 2020 Feb; 17(1):14. PubMed ID: 32024544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury.
    Kleindienst A; Meissner S; Eyupoglu IY; Parsch H; Schmidt C; Buchfelder M
    Acta Neurochir Suppl; 2010; 106():247-50. PubMed ID: 19812958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders.
    Kuehne LK; Reiber H; Bechter K; Hagberg L; Fuchs D
    J Psychiatr Res; 2013 Oct; 47(10):1417-22. PubMed ID: 23790260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived protein concentrations in the cerebrospinal fluid: contribution of trauma resulting from ventricular drain insertion.
    Brandner S; Thaler C; Buchfelder M; Kleindienst A
    J Neurotrauma; 2013 Jul; 30(13):1205-10. PubMed ID: 23390981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper reference limits for cerebrospinal fluid total protein and albumin quotient based on a large cohort of control patients: implications for increased clinical specificity.
    Hegen H; Auer M; Zeileis A; Deisenhammer F
    Clin Chem Lab Med; 2016 Feb; 54(2):285-92. PubMed ID: 26079822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.
    Reiber H
    J Neurol Sci; 1994 Apr; 122(2):189-203. PubMed ID: 8021703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of S100B in cerebrospinal fluid as a potential biomarker for neurological diseases in calves.
    Kojima Y; Chiba S; Horiuchi N; Kobayashi Y; Inokuma H
    J Vet Med Sci; 2015 May; 77(5):605-7. PubMed ID: 25649061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Cepek L; Steinacker P; Mollenhauer B; Wiese B; Ciesielczyk B; Bibl M; Wiltfang J; Zerr I; Schulz-Schaeffer W; Kretzschmar HA; Poser S; Otto M
    Dement Geriatr Cogn Disord; 2005; 19(5-6):376-82. PubMed ID: 15802913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function.
    Gressner OA; Schifflers MC; Kim P; Heuts L; Lahme B; Gressner AM
    Clin Chim Acta; 2009 Feb; 400(1-2):86-90. PubMed ID: 19000909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease.
    Stoeck K; Bodemer M; Zerr I
    J Neuroimmunol; 2006 Mar; 172(1-2):175-81. PubMed ID: 16330103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
    Jesse S; Steinacker P; Cepek L; von Arnim CA; Tumani H; Lehnert S; Kretzschmar HA; Baier M; Otto M
    J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis.
    Barateiro A; Afonso V; Santos G; Cerqueira JJ; Brites D; van Horssen J; Fernandes A
    Mol Neurobiol; 2016 Aug; 53(6):3976-3991. PubMed ID: 26184632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acids as markers of the blood-cerebrospinal fluid barrier function in man.
    Roelcke U; Heil J
    Funct Neurol; 1993; 8(3):189-92. PubMed ID: 8406137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
    Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
    Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
    Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative delirium and changes in the blood-brain barrier, neuroinflammation, and cerebrospinal fluid lactate: a prospective cohort study.
    Taylor J; Parker M; Casey CP; Tanabe S; Kunkel D; Rivera C; Zetterberg H; Blennow K; Pearce RA; Lennertz RC; Sanders RD
    Br J Anaesth; 2022 Aug; 129(2):219-230. PubMed ID: 35144802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections.
    Peng QL; Tao SH; Yu N; Zhou XZ; Peng YZ; Fu N
    Int J Neurosci; 2017 Jan; 127(1):1-9. PubMed ID: 26710878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune activation markers neopterin and β2-microglobulin are not elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Stoeck K; Zerr I
    J Neuroimmunol; 2011 Apr; 233(1-2):228-32. PubMed ID: 21232804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [S100B protein serum level as a biomarker of minor head injury].
    Beaudeux JL; Laribi S
    Ann Biol Clin (Paris); 2013 Nov; 71():71-8. PubMed ID: 24235330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.